A progressive neurodegenerative disorder characterized by memory loss and cognitive decline, associated with cortical atrophy.Alzheimer's disease is a progressive neurodegenerative disorder and the most common cause of dementia. It is characterized by a gradual loss of memory, reasoning, and the ability to perform everyday tasks, accompanied by structural changes in the brain, most notably cortical atrophy — the shrinking of the cerebral cortex. The disease is defined by the accumulation of abnormal protein aggregates: extracellular amyloid-beta plaques and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. These pathological hallmarks disrupt synaptic communication, trigger neuroinflammation, and ultimately lead to neuronal death, particularly in regions critical for memory such as the hippocampus and entorhinal cortex.
Alois Alzheimer first described the disease in 1906 after examining the brain of Auguste Deter, a patient with severe memory loss and disorientation. He identified the distinctive plaques and tangles that now bear his name. The condition was named Alzheimer's disease by Emil Kraepelin in 1910.
The disease process begins decades before clinical symptoms appear. Amyloid-beta peptides, normally cleared from the brain, begin to misfold and clump into plaques, while tau proteins detach from microtubules and form tangles inside neurons. This triggers a cascade of events: synaptic dysfunction, mitochondrial damage, oxidative stress, and chronic activation of microglia, the brain's immune cells. As neurons die, the brain loses volume — visible as cortical atrophy on MRI scans — and the white matter tracts connecting regions degenerate, disrupting neural networks. The progression follows a characteristic pattern, starting in medial temporal lobe structures and spreading through the default mode network, which is why memory and spatial navigation are affected first.
Neuroimaging techniques such as MRI and PET are used to detect cortical atrophy and amyloid deposition for early diagnosis, while computational models of brain networks help predict disease progression and personalize treatment strategies.
The brain of an Alzheimer's patient can lose up to 20% of its total weight by the late stages of the disease, with the hippocampus shrinking by as much as 40%.




